Latest Commercialization News

Page 5 of 481
Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.
Victor Sage
Victor Sage
2 Apr 2026
Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.
Sophie Babbage
Sophie Babbage
2 Apr 2026
Emyria Limited has launched a targeted recruitment campaign in New South Wales to establish its fourth state-based clinical operation, aiming to tap into Australia's largest mental health market amid rising psychological injury claims.
Ada Torres
Ada Torres
2 Apr 2026
Beetaloo Energy has received a $15.4 million R&D tax refund, reinforcing its financial position as it advances key milestones in the Carpentaria Pilot Project towards gas production and sales in 2026.
Maxwell Dee
Maxwell Dee
2 Apr 2026
NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Orion Minerals secures a major milestone as South Africa’s IDC converts its loan into a significant equity stake in the Prieska Project, streamlining financing and advancing development plans.
Maxwell Dee
Maxwell Dee
2 Apr 2026
X2M Connect has inked a binding agreement to deploy its Smart Energy solution across a 1,000-lot residential estate in Victoria, unlocking a potential $2 million revenue opportunity and setting the stage for broader expansion.
Sophie Babbage
Sophie Babbage
2 Apr 2026
Syrah Resources has opened its retail entitlement offer to raise approximately A$104 million, supported by strategic funding proposals from US and Australian government-linked entities. The capital raise aims to underpin the ramp-up of its Balama graphite mine and Vidalia anode material facility.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Harvest Technology Group is sharpening its focus on defence markets following an independent review that validates its Nodestream platform’s relevance. The company has initiated third-party validation and made significant leadership changes, including the CEO’s departure.
Sophie Babbage
Sophie Babbage
2 Apr 2026
Healthscope has paid all rent due through April 2026 for hospitals owned by HealthCo Healthcare & Wellness REIT, while alternative operators submit plans to take over hospital operations.
Eva Park
Eva Park
1 Apr 2026
Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.
Ada Torres
Ada Torres
1 Apr 2026
Arovella Therapeutics has demonstrated that its novel CLDN18.2-targeting CAR incorporated into iNKT cells effectively eliminates pancreatic and gastric cancer cells in vitro, with IL-12-TM armouring enhancing potency and durability.
Ada Torres
Ada Torres
1 Apr 2026